Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis

Carina Blomström Lundqvista Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

Sara Själanderb Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

Luis A. Garcia Rodriguezc Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain

Örjan Åkerborgd Wickenstones Ltd., Carlow, Ireland

Guanyi Jind Wickenstones Ltd., Carlow, Ireland

Amrit Caleyachettyd Wickenstones Ltd., Carlow, Ireland

Maria Huelsebecke Bayer AG, Berlin, Germany

Kevin Bowrinf Bayer Plc, Reading, UK

Bernhard Schaefere Bayer AG, Berlin, Germany

Hovsep Mahdessiang Bayer AB, Stockholm, Sweden

Lucas Hofmeistere Bayer AG, Berlin, Germany

Lars-Åke Levinh Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, SwedenCorrespondence[email protected]

Your download is now in progress and you may close this window